Solarea Bio is a biotechnology company based in Cambridge, MA developing new microbiome-based solutions to some of the world's largest health problems. Solarea was founded in 2017 by a group of scientists and entrepreneurs eager to radically alter our understanding of the human microbiome and utilize its power to improve human health.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/19/20 | $11,200,000 | Series A |
Bold Capital GISEV Family Office S2G Ventures  | undisclosed |
| 05/08/23 | $15,000,000 | Series B |
BOLD Capital Partners GG 1978 SICAF SIF S2G Ventures Viking Global Investors | undisclosed |
